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Abstract
Background: Slowed muscle relaxation is the contractile hallmark of myotonia congenita, a disease caused by
genetic CLC-1 chloride channel deficiency, which improves with antecedent brief contractions ("warm-up
phenomenon”). It is unclear to what extent the myotonia continues to dissipate during continued repetitive
contractions and how this relates temporally to muscle fatigue. Diaphragm, EDL, and soleus muscles were
examined in vitro during repetitive 20 Hz and 50 Hz train stimulation in a drug-induced (9-AC) rat myotonia
model.
Results: At the onset of stimulation, 9-AC treated diaphragm and EDL muscle had markedly prolonged half
relaxation and late relaxation times (range 147 to 884 ms, 894 to 1324 ms). Half relaxation and late relaxation times
reached near-normal values over the 5-10 and 10-40 subsequent contractions, respectively. In both muscles
myotonia declined faster during repetitive 50 Hz than 20 Hz stimulation, and much faster than the rate of force
loss during fatigue at both frequencies. Soleus muscle was resistant to the myotonic effects of 9-AC.
Conclusions: In a drug-induced model of mechanical myotonia, fatigue-inducing stimulation resolves the
myotonia, which furthermore appears to be independent from the development of muscle fatigue.
Background
Slowed muscle relaxation due to persistent electrical dis-
charges is the hallmark of myotonia [1-4]. Myotonia
occurs naturally in several species (humans, goats, mice)
as a result of genetic deficiency of the skeletal muscle
CLC-1 channel, a disease which in humans is termed
myotonia congenita [1-13]. It can also be produced
experimentally by blocking muscle Cl
- channels of nor-
mal muscle, for example with 9-anthracene carboxylic
acid (9-AC), p-chloro-phenoxy-propionic acid, or 2,4-
dichlorphenoxyacetate [4,14-16]. Muscle from humans
and animals with myotonia congenita has physiological,
structural and biochemical alterations which transcend
the loss of CLC-1 channels, including hypertrophy (goats,
most humans) or atrophy (mice), alterations in fiber type
composition (in particular loss of type IIB fibers, seen in
most species with myotonia congenita), and altered
amounts of parvalbumin [1,5,7,9,11-13,17,18]. These
downstream changes may contribute to the complex
abnormalities in contractile performance found in CLC-1
deficient muscle, in particular changes that occur during
the contractile phase of the contraction-relaxation cycle,
such as impaired force production and alterations in rate
of fatigue during isometric contractions [19].
Humans with myotonia experience limb muscle stiff-
ness which interferes particularly with the initiation of
movements [3,20-22]. Involvement of respiratory mus-
cles may lead to “breathing difficulties”, dyspnea, sleep
apnea, and daytime alveolar hypoventilation [23-26]. For
many subjects the myotonia has an adverse effect on
their ability to engage in sports [2,21-23]. The extent of
myotonia, however, dissipates with repetitive contrac-
tions, the so-called warm-up phenomenon [2-4,16,21].
This has been examined in the context of a short series
of low intensity contractions reducing myotonia during
subsequent low intensity contractions [7,16,20,27] rather
than in the context of repetitive contractions of suffi-
cient severity to produce fatigue, such as might occur
during athletic activities.T h eg e n e r a lp u r p o s eo ft h e
present study was therefore to examine myotonia during
fatigue-inducing stimulation. Based on previous studies
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fatiguing contractions, the specific hypotheses of the
present study were that a) myotonia declines more
rapidly than force during fatigue-inducing stimulation,
and b) the rate of decline of the myotonia during fati-
gue-inducing stimulation is affected by the frequency of
stimulation producing fatigue (specifically higher stimu-
lation frequencies augment the rate of dissipation).
In order to avoid the effects of downstream structural
and biochemical changes (eg., alterations in fiber
type composition and atrophy or hypertrophy
[1,5,7,9,11-13,17,18]) resulting from genetic CLC-1
channel deficiency that can affect muscle fatigue proper-
ties in manners apart from the myotonia itself, the pre-
sent study utilized Cl
- channel blockade with 9-AC to
produce myotonia in otherwise normal muscle rather
than testing muscle that is genetically deficient in Cl
-
channels. Muscles pertinent to breathing (diaphragm),
fast twitch movements (EDL), and slow twitch move-
ments (soleus) were tested to determine whether 9-AC
has varying effects on muscles with different fiber type
compositions.
Methods
Studies were performed using adult male Sprague-
Dawley rats (n = 35, weight = 390 ± 15 grams). All pro-
tocols were approved by the Institutional Animal Care
and Use Committee and conformed to animal care
guidelines established by the National Institutes of
Health. Rats were well-anesthetized using a rodent anes-
thetic cocktail (initial dose, ketamine 21-30 mg/kg, xyla-
zine 4.3-6.0 mg/kg and acepromazine 0.7-1.0 mg/kg,
with supplemental smaller doses given as needed to pro-
duce and maintain a deep level of anesthesia). The EDL
and soleus muscles were removed from the legs with
intact tendons, and the diaphragm muscles were
removed with intact rib origins and central tendon
insertions. Contractile studies were performed in physio-
logical solution consisting of (in mM): 135 NaCl, 5 KCl,
2.5 CaCl2, 1 MgSO4, 1 NaH2PO4, 15 NaHCO3, and 11
glucose, with the pH adjusted to 7.35-7.45 at 37°C while
being aerated with 95% O2-5%CO2. The diaphragm
muscle was cut into small strips parallel to the fiber
direction keeping origin and insertion intact (strip width
~5 mm), and mounted vertically in a double-jacketed
chamber while the temperature was maintained at 37°C.
The soleus and EDL muscles were similarly mounted in
the same chamber by the attached tendons, except that
they were left whole and not cut into strips like the dia-
phragm. A pair of platinum electrodes was placed paral-
lel to the diaphragm muscle strips or limb muscles, and
supramaximal voltages were delivered with a pulse
width of 1 ms. The lengths of the muscle samples were
adjusted until the twitch force was maximized (optimal
l e n g t h ) ,a n dk e p ta tt h i sl e n g t hf o rt h ed u r a t i o no ft h e
contractile study.
Ten minutes after the diaphragm muscle or limb mus-
cle (at optimal length) had equilibrated to the Kreb’s
solution, three twitch contractions were recorded
10 seconds apart to determine the baseline force of the
muscle. Three minutes thereafter, another three twitches
were recorded 10 seconds apart to verify stability of the
muscle sample (defined as <5% variability in force
between first and second set of twitches). Subsequently
1m lK r e b ’s solution containing 9-AC was added to half
of the muscle samples to obtain a bath concentration of
100 μM, and to the other half of the muscle samples
1m lo ft h eK r e b ’s solution without 9-AC was added.
Twenty minutes later repetitive train stimulation was
initiated. This consisted of intermittent 20-Hz or 50-Hz
train stimulations, with a train length of 0.33 s and one
train every three seconds. The relatively long inter-train
interval was needed due to the markedly slowed rate of
relaxation in the presence of 9-AC, as this allowed time
for muscle force to return back to baseline prior to the
subsequent train. Due to the slow isometric kinetics of
the soleus muscle, contractions have a high degree of
fusion during 50 Hz stimulation, impairing the ability to
measure contraction and relaxation times. Therefore
soleus was only studied during 20 Hz stimulation.
Muscle contractile performance was assessed with
respect to four parameters (Figure 1), and in all
i n s t a n c e st h i sw a sr e l a t i v eto baseline passive tension.
Peak force was defined as the largest value that occurred
during the portion of the contraction while the muscle
was being electrically stimulated (and thus did not
include mechanical myotonia even if mechanical myoto-
nia exceeded force during active electrical stimulation).
These force values were normalized relative to twitch
force before drug addition to factor out the effects of
variability among muscle samples in absolute force
related to variability in animal size and muscle sample
size, similar to previous studies of a similar nature
[11,15,19,22]. Contraction time was defined as the time
from the onset of force production to the top of the
first peak of the non-fused contraction; values for con-
traction time are not presented in those instances in
which a distinct first peak was not discernable (which
was the case for 50 Hz stimulation for the diaphragm).
H a l f - r e l a x a t i o nt i m ew a st h et i m er e q u i r e df o rf o r c et o
decrease from the peak value at the end of electrical sti-
mulation to 50% of this value. Late relaxation time was
the time for force to decline from 50% of peak to 10%
of peak. These four values were quantified for a total
duration of six minutes. All data presented are means
and SD. Statistical analysis of paired data was performed
with a paired t-test. Statistical analysis of data obtained
during repetitive stimulation was performed with
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the Newman-Keuls post-hoc test in the event of signifi-
cance by analysis of variance. The level for statistical sig-
nificance was set at P < 0.05 (two tailed).
Results
Diaphragm
The effects of 9-AC on diaphragm force, contraction
time, half relaxation time and late relaxation time at the
outset of repetitive stimulation are listed in Table 1. 9-
AC increased force and contraction time during 20 Hz
but not 50 Hz stimulation. Half relaxation and late
relaxation times increased during both 20 Hz and 50 Hz
stimulation, reaching values in the hundreds of millise-
conds. Furthermore, values were generally longer for
late relaxation (~1 to 1.5 seconds) than for the half-
relaxation time (~0.5 to 1 second). None of these para-
meters changed at the outset of repetitive stimulation in
the control muscle samples which were not treated with
9-AC.
Force values for diaphragm during repetitive 20 and
50 Hz stimulation are depicted in Figure 2A. During 20
Hz repetitive stimulation, force declined rapidly in
muscles that were treated with 9-AC after the initial 9-
AC-induced augmentation. At one minute into the fati-
gue-inducing stimulation and all points thereafter, force
values were equivalent in 9-AC treated and untreated
muscles. In contrast, force values did not differ for
drug-treated and untreated diaphragm at any time dur-
ing 50 Hz stimulation. Contraction time also was pro-
longed by 9-AC during 20 Hz stimulation (Figure 2B)
and not measurable during 50 Hz stimulation because
successive stimulation was 20 ms apart and contraction
time was greater than 20 ms. This prolongation waned
with repetitive fatigue-inducing stimulation, but did not
fully dissipate over the course of six minutes.
Both the half relaxation time (Figure 2C) and the late
relaxation time (Figure 2D) were prolonged substantially
by 9-AC, but eventually declined to normal or near-
normal values during fatigue-inducing stimulation. The
decline was more precipitous for the early compared to
the late phase of relaxation as well as during 50 Hz
compared with 20 Hz stimulation. The rate at which
myotonia resolved was much faster than the rate at
which force decreased, in that myotonia was almost
completely resolved over the first 60 seconds of
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Figure 1 Parameters measured for a diaphragm myotonic contraction at 20 Hz. The baseline is passive force related to stretching the
muscle to optimal length, and all other active force values were quantified relative to baseline.
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full duration of stimulation (compare Figures 2C and
2D with Figure 2A). Furthermore, during 50 Hz stimula-
tion the mechanical myotonia was substantially resolved
before there was any appreciable force loss.
Limb Muscles
Soleus muscle did not demonstrate myotonia in
response to 9-AC (data shown for 20 Hz stimulation in
Figure 3). There was a mild increase in force (Figure
3A), but contraction time (Figure 3B), half relaxation
time (Figure 3C) and late relaxation time (Figure 3D)
were unaffected.
In contrast, the response of EDL was similar in most
respects to that of the diaphragm. Peak EDL force
increased during 20 Hz but only minimally so during
50 Hz stimulation (Figure 4A), and for 20 Hz stimulation
this waned over time with repetitive stimulation. However,
contraction time was not altered by 9-AC at either stimu-
lation frequency (Figure 4B). Both half-relaxation time
(Figure 4C) and late relaxation time (Figure 4D) of the
EDL were prolonged by 9-AC. All relaxation times pro-
longed by 9-AC normalized rapidly during repetitive sti-
mulation, and this occurred faster than the rate at which
force declined, in that myotonia was almost completely
resolved over the first 30 seconds of stimulation whereas
force continued to decline for the full duration of stimula-
tion (compare Figures 4C and 4D with Figure 4A). As
seen with the diaphragm, during 50 Hz stimulation the
mechanical myotonia was substantially resolved before
there was any appreciable force loss.
Discussion
The inability of muscles to relax normally after volun-
tary contractions is characteri s t i co ft h ed i s e a s em y o t o -
nia. The results of this study showed that mechanical
myotonia decreases rapidly during fatigue-inducing sti-
mulation. Furthermore, myotonia was found to decrease
faster than force in both the diaphragm and EDL mus-
cles. The normalization of relaxation times was slightly
faster at a higher frequency (50 Hz) than a lower fre-
quency (20 Hz) in the diaphragm muscle; however this
may have been due to the effects of myotonia being less
during 50 Hz than 20 Hz stimulation. Furthermore, the
resolution of myotonia was also slightly faster in the
EDL muscle than the diaphragm muscle, although again
possibly because of differences in the magnitude of the
myotonia. Both the diaphragm and EDL muscles had
much larger degrees of myotonia than the soleus in
response to 9-AC. In addition, force production
increased at the lower stimulation frequency (20 Hz) in
the diaphragm and EDL, and increased slightly in the
soleus at this frequency, but did not increase at the
higher frequency (50 Hz) in any of the three muscles
with 9-AC. Contraction time increased only in the dia-
phragm during 20 Hz stimulation.
Myotonia, whether genetically- or drug-induced,
decreases during repeated contractions, this resolution
being termed the “warm up” phenomenon. This has
been described in clinical reports of humans with myo-
tonia congenita and is also apparent when observing the
behavior of genetically myotonic mice [2,3,21]. Physiolo-
gical manifestations when tested experimentally include
improved rate of muscle relaxation and diminution of
the duration and intensity of persistent electromyo-
graphic activity following repetitive muscle activation.
One of the early experimental studies of the warm up
phenomenon was that performed by Senges and Rudel
[16] in a model of myotonia induced by 2,4-dichlorphe-
noxyacetate. They examined the effects of a condition-
ing tetanus preceding a test contraction by 0.5, 1, 2 and
4 seconds. The shortest time interval virtually abolished
myotonia, with the effect diminishing markedly as the
time interval increased.
The warm up phenomenon was described by Heller
et al.[7] in the original report of genetically myotonic
mice. This was demonstrated based on electromyo-
graphic recordings from affected muscle in response to
direct peripheral nerve stimulation rather than on mea-
surements of muscle force. Heller and colleagues [7]
Table 1 The outset of repetitive stimulation during 20 Hz and 50 Hz stimulation
Stimulation Measurement Frequency Stimulation Before Krebs After Krebs Before 9-AC After 9-AC
Peak force (% of initial) 20 Hz 138 ± 8 142 ± 10 155 ± 21 315 ± 53*
50 Hz 319 ± 65 345 ± 91 293 ± 47 356 ± 58
Contraction time (ms) 20 Hz 23.7 ± 2.3 23.8 ± 1.2 23.2 ± 2.8 44.8 ± 6.7*
50 Hz 20.1 ± 0.9 20.6 ± 1.3 20.0 ± 0.7 20.7 ± 1.2
Half relaxation time (ms) 20 Hz 26.0 ± 4.4 26.5 ± 1.7 29.2 ± 5.0 883.5 ± 296.0*
50 Hz 26.4 ± 1.6 27.9 ± 2.6 28.6 ± 3.2 421.7 ± 308.3*
Late relaxation time (ms) 20 Hz 45.5 ± 11.8 51.4 ± 10.4 73.6 ± 50.8 1324.4 ± 339.2*
50 Hz 32.0 ± 6.0 34.5 ± 3.9 28.6 ± 8.0 1142.6 ± 504.9*
The effect of Kreb’s solution and 9-AC on diaphragm muscle at the outset of repetitive stimulation on peak force, contraction time, half relaxation time, and late
relaxation time during 20 Hz and 50 Hz stimulation. Values are means ± SD. Asterisks indicate significant differences between before and after 9-AC data.
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Figure 2 The effect of 9-AC on force production, contraction time, half relaxation time and late relaxation time in diaphragm muscle
during repetitive 20 Hz and 50 Hz train stimulation. Contraction time was not measurable at 50 Hz. Values are means and bars indicate SD.
P values are the results of analysis of variance; asterisks indicate significant differences found by the Newman-Keuls test in the event of
significance by analysis of variance.
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at 10 second intervals, but recovering when the muscle
has rested for one minute.
The warm-up phenomenon was also studied by Hei-
mann et al [27]. EDL muscles from myotonic ADR
mutants and ADR-MDX double mutants were shown to
have similar degrees of myotonia as quantified by the
myotonia index [28] (myotonia index of 0.49 vs. 0.57,
respectively). Furthermore, they had similar degrees to
which the myotonia improved when contractions were
preceded by a series of single twitches and incomplete
tetanic stimulations. However, the study also found that
myotonia symptoms were more pronounced in ADR
than ADR-MDX muscle, but ADR-MDX mice had
higher levels of weight reduction and premature death.
In contrast, for the soleus the ADR mutant had a signif-
icantly higher myotonia index than the ADR-MDX
mutant (myotonia index of 0.90 vs. 0.61). Data for the
warm up phenomenon were not depicted for the soleus.
Van Beekvelt et al. [21] studied three humans with
myotonia and defined the warming-up phenomenon as
the force recovery phase after initial paresis during a
sustained voluntary contraction. This study hypothesized
that warming-up was due to the enhanced activation of
Na+-K+-ATPase during exercise, and used ouabain
(a Na+-K+-ATPase inhibitor) to test this. However, it
was found that ouabain infusion did not prevent recov-
ery from transient paresis. Therefore, it was concluded
that the warm-up phenomenon was not due to Na+-K
+-ATPase.
Taken together, the above studies provide a compre-
hensive picture of the manner in which myotonia
improves following brief contractions, but these studies
had not examined changes in myotonia during the
course of repetitive fatigue-inducing contractions. The
latter issue has been examined to a limited extent in a
previous study from our lab in which we examined iso-
tonic contractions of diaphragm muscle from genetically
Figure 3 The effect of 9-AC on peak force, contraction time, half relaxation time, and late relaxation time in the soleus muscle during
repetitive 20 Hz train stimulation. Values are means and bars indicate SD. P values are the results of analysis of variance; asterisks indicate
significant differences found by the Newman-Keuls test in the event of significance by analysis of variance.
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Page 6 of 9Figure 4 The effect of 9-AC on force production, contraction time, half relaxation time and late relaxation time in the EDL (extensor
digitorum longus) muscle during repetitive 20 Hz and 50 Hz train stimulation. Values are means and bars indicate SD. P values are the
results of analysis of variance; asterisks indicate significant differences found by the Newman-Keuls test in the event of significance by analysis of
variance.
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Page 7 of 9myotonic mice [19]. Diaphragm from these mice had
lesser degrees of myotonia than seen in the diaphragm
of the present study. Total relaxation time during a
singe train contraction ranged from ~0.2 to 0.6 seconds
in contrast to values exceeding 2 seconds with 9-AC in
the present study. In the genetically myotonic mice,
repetitive train stimulation at a frequency of 50 Hz
resulted in a rapid reduction in relaxation time over the
course of 30 seconds, with minimal changes thereafter
during the subsequent 30 seconds.
The present study expands on our previous findings
[19] in several manners. We found that the reduction of
myotonia during fatigue-inducing contractions occurs
during isometric as well as isotonic contractions, and in
the drug-induced myotonia model as well as genetic
myotonia. Furthermore, the present study indicates that
the resolution of myotonia varies as a function of the
frequency of muscle stimulation. In addition the extent
of drug-induced myotonia differed among the three
muscles studied, with the slow fiber type predominance
of the soleus appearing to have had a protective effect.
Finally, the present data indicate that the time course of
the warm-up phenomenon is much faster than that of
force loss during fatigue-inducing contractions.
One of the limitations of the present study is that
the studies were done in vitro, under conditions in
which there is no blood flow and thus no delivery of
nutrients and/or impaired removal of potentially
adverse metabolites. Thus the development of fatigue
may have occurred faster in the drug-induced myoto-
nia model than would occur in vivo in humans or ani-
mals with genetic CLC-1 chloride channel deficient
myotonia. A second limitation is that the genetic mus-
cle diseases that cause myotonia are a heterogeneous
group which include not only two variants of CLC-1
deficient myotonia but also myotonic dystrophy. Sev-
eral of these disorders have features in addition to the
myotonia, which for some includes muscle weakness.
Among these additional features, muscle weakness in
particular may impact the rate at which fatigue devel-
ops, thereby changing the temporal relationship
between the improvement of the myotonia and the
reduction of force in response to repetitive vigorous
contractions.
Conclusions
Fatigue-inducing contractions were shown to dissipate
the amount of mechanical myotonia induced by the
chloride channel blocker 9-AC. However the rate at
which this occurred was considerably faster than the
drop in force over time, consistent with different
mechanisms accounting for the warm up phenomenon
and the production of fatigue. From a clinical perspec-
tive this suggests that subjects with myotonia need not
warm up to a sufficiently large extent to produce muscle
fatigue in order for the myotonia to dissipate, but none-
theless suggest a role for vigorous rather than more
modest contractions as a means for resolving the muscle
myotonia more quickly.
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